AGLE
Real-time Quotes | Nasdaq Last Sale
Based on 8 analysts
Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.
3 Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
Feb 25,2021 19:30
3 Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
Feb 25,2021 19:30
4 Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
Feb 25,2021 19:31
8-K Aeglea BioTherapeutics, Inc. (0001636282) (Filer)
Feb 24,2021 16:30
4 Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
Feb 19,2021 17:09
4 Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
Feb 19,2021 17:09
4 Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
Feb 19,2021 17:07
4 Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
Feb 19,2021 17:08
SC 13G/A Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
Feb 16,2021 16:53
SC 13G/A Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
Feb 16,2021 15:14
SC 13G/A Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
Feb 16,2021 10:21
SC 13G/A Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
Feb 12,2021 16:39
SC 13G Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
Feb 12,2021 16:59
SC 13G/A Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
Feb 11,2021 07:31
SC 13G Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
Feb 10,2021 11:37
SC 13G/A Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
Feb 10,2021 06:35
3 Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
Feb 08,2021 19:51
8-K Aeglea BioTherapeutics, Inc. (0001636282) (Filer)
Feb 03,2021 16:31
8-K Aeglea BioTherapeutics, Inc. (0001636282) (Filer)
Jan 05,2021 08:30
4 Aeglea BioTherapeutics, Inc.
Dec 17,2020 16:33
Webull offers kinds of Aeglea Bio Therapeutics Inc stock information, including NASDAQ:AGLE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AGLE stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading AGLE stock methods without spending real money on the virtual paper trading platform.